Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.

Menzo S, Vincenti D, Solmone M, Prosperi M, Bruselles A, Abbate I, Rozera G, Capobianchi MR.

J Infect Dis. 2009 Dec 1;200(11):1798-9; author reply 1799-1800. doi: 10.1086/647991. No abstract available.

PMID:
19905934
2.

Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.

Buti M.

IDrugs. 2008 Apr;11(4):239-41. No abstract available.

PMID:
18379952
3.

The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients.

Gelinck LB, Claas EC, Kroon FP.

J Hepatol. 2005 Aug;43(2):360-1; author reply 361. No abstract available.

PMID:
15970350
4.
5.

Cellular and virological mechanisms of HBV drug resistance.

Locarnini S, Mason WS.

J Hepatol. 2006 Feb;44(2):422-31. Epub 2005 Dec 7. Review. No abstract available.

PMID:
16364492
6.

HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies.

Mascolini M, Mellors JW, Richman DD, Boucher CA, Larder BA.

Antivir Ther. 2011;16(2):263-86. doi: 10.3851/IMP1761.

PMID:
21447877
7.

Hepatitis B virus escape mutants induced by antiviral therapy.

Sheldon J, Soriano V.

J Antimicrob Chemother. 2008 Apr;61(4):766-8. doi: 10.1093/jac/dkn014. Epub 2008 Jan 24. Review.

PMID:
18218641
8.

Designing a low-cost drug resistance database for viral hepatitis.

Kuiken C.

Antivir Ther. 2010;15(3 Pt B):517-20. doi: 10.3851/IMP1554. Review.

PMID:
20516573
9.

Technique for the early detection of drug-resistant HBV DNA during antiviral therapy.

Yeon JE.

Intervirology. 2008;51 Suppl 1:7-10. doi: 10.1159/000122593. Epub 2008 Jun 10. Review.

PMID:
18544942
10.

The mechanisms of action of antivirals against hepatitis B virus infection.

Kamiya N.

J Antimicrob Chemother. 2003 May;51(5):1085-9. Epub 2003 Apr 14. Review. No abstract available.

PMID:
12697634
11.

[Sequence detection of HBV-DNA P and C region in HIV/HBV superinfection subjects with drug resistance to HAART].

ZHu B, Wu NP, Bader A, Brockmeyer N.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2003 Dec;32(6):507-9. Chinese.

PMID:
14712514
12.

New developments in the management of hepatitis B virus/HIV coinfection.

Chung RT.

MedGenMed. 2002 Sep 3;4(3):20. Review. No abstract available.

13.
14.

Butting heads with resistance.

Shafer RW.

IAPAC Mon. 2006 Jun;12(6):180-9. No abstract available.

PMID:
17233105
15.

Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.

Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.

J Med Virol. 2009 Jul;81(7):1151-6. doi: 10.1002/jmv.21505.

PMID:
19475624
16.

HBV drug resistance: mechanisms, detection and interpretation.

Shaw T, Bartholomeusz A, Locarnini S.

J Hepatol. 2006 Mar;44(3):593-606. Epub 2006 Jan 19. Review. No abstract available.

PMID:
16455151
17.

Persistence of HIV drug resistance mutations: more clues from clinical observations.

Jenny-Avital ER, Stein DK.

Clin Infect Dis. 2004 May 15;38(10):1507-8. No abstract available.

PMID:
15156499
18.

Virology of hepatitis B and C viruses and antiviral targets.

Pawlotsky JM.

J Hepatol. 2006;44(1 Suppl):S10-3. Epub 2005 Nov 21. Review.

PMID:
16338022
19.

Hepatitis B virus infection.

Dienstag JL.

N Engl J Med. 2008 Oct 2;359(14):1486-500. doi: 10.1056/NEJMra0801644. Review. No abstract available. Erratum in: N Engl J Med. 2010 Jul 15;363(3):298.

PMID:
18832247
20.

HIV Variants and Hepatitis B Surface Antigen Mutants. Proceedings of a symposium, May 22-24, 2005, Washington, DC, USA.

[No authors listed]

J Med Virol. 2006;78 Suppl 1:S1-70. No abstract available.

PMID:
16937554

Supplemental Content

Support Center